02.01.2017
Prevent & Delay
$300,000.00
36 months
Type 1 Diabetes (T1D) Biomarker Consortium
Funds will support the Critical Path Institute and its partners in regulatory qualification of islet autoantibodies as biomarkers of disease in type 1 diabetes.